Latest Recruitments & Recent News

The Chase Group Successfully Completes Search for Amyloidosis Medical Affairs Leader

The Chase Group Identifies Chief Medical Officer for Arcturus Therapeutics

The Chase Group Secures VP, Head of Regulatory Affairs, for Checkmate Pharmaceuticals

The Chase Group Secures Teng Jin Ong for Genmab

The Chase Group Secures Clinical Operations Leadership for Alexza Pharmaceuticals

Leadership Team Grows at Biologics Consulting Through Partnership With The Chase Group

The Chase Group Successfully Completes Search for Vice President, Research & Development at Alexza Pharmaceuticals

The Chase Group Successfully Places David Geller, MD as Head of Pulmonary & Rare Disease Clinical Development for Arcturus Therapeutics

The Chase Group Continues Successful Collaboration with Genmab Through Placement of Vice President, CDTL

The Chase Group Successfully Secures Vice President, Head of Medical Development for Checkmate Pharmaceuticals

Search Executed by The Chase Group, Inc. Results in Successful Appointment of Dr. Christophe Hotermans as SVP, Global Medical Affairs for Akcea Therapeutics

Appointment of William Andrews, M.D. as Chief Medical Officer at Akcea Therapeutics Successfully Completed by The Chase Group

The Chase Group Secures New Leader for Informatics & Computational Biology at the Allen Institute for Immunology

The Chase Group Successfully Completes the Appointment of Carla Poulson as Senior Vice President/Chief Human Resources Officer at Akcea Therapeutics

The Chase Group Secures Director of Drug Safety in Copenhagen/Denmark for Genmab

Partnership With The Chase Group Results in Successful Placement for Eisai Global Oncology Business Unit

Aeglea Biotherapeutics Secures Another Executive for their Clinical Development Leadership Team

A New Era Begins with Head of Pathology Placement at Genmab

Aeglea BioTherapeutics Builds Rare Disease Clinical Development Team Through Partnership With The Chase Group, Inc.

Ionis Pharmaceuticals Secures Associate Director, Investor Relations

The Chase Group Secures the Vice President, Global Head of Data Sciences, for Genmab

A Successful Placement at Eisai, Inc.

Another Key Placement by The Chase Group

The Chase Group Successfully Completes Vice President, Clinical Development, Respiratory for Ionis Pharmaceuticals

Corporate Communications Executive Secured for Ipsen Biopharmaceuticals

Vice President of Drug Safety for Ionis Pharmaceuticals Secured

Ionis Engages The Chase Group to Continue Building QA Team

Ipsen Retains The Chase Group for Senior Marketers

Head of Regulatory Affairs Secured for Marinus

The Chase Group completes CMO search with Akcea Therapeutics

Entasis Therapeutics

Akcea Therapeutics

Ionis Director, Global HEOR, Rare Disease Immunology, Successfully Placed by The Chase Group

Atsena Therapeutics Process Development Opportunity

Arcturus Retains The Chase Group to Expand Vaccine Development Programs

Ionis VP Medical Affairs Successfully Placed by The Chase Group

The Chase Group Secures SVP, Regulatory for Atsena Therapeutics in Impressive Timeframe

The Chase Group Retained to Identify Vice President, Manufacturing/Supply Chain

Successful Collaboration Results in VP Finance Placement at Ionis

Alexza Pharmaceuticals Partnership Continues with Quality Assurance Leadership Search

Atsena Therapeutics Retains The Chase Group to Identify Head of Regulatory

Ventria Continues Partnership With The Chase Group to Find Agronomy Operations Leader

The Chase Group Secures VP, Head of Regulatory Affairs, for Checkmate Pharmaceuticals

The Chase Group Secures Teng Jin Ong for Genmab

Ventria Bioscience Cuts to The Chase!

Genmab Continues Partnership With The Chase Group As Their Drug Safety Leadership Team Grows

Ferrer Partners With The Chase Group to Identify US Business Development Leader

The Chase Group Secures Clinical Operations Leadership for Alexza Pharmaceuticals

The Chase Group Identifies Chief Medical Officer for Arcturus Therapeutics

Alexza Pharmaceuticals Continues Partnership With The Chase Group to Seek Clinical Operations Leader

The Chase Group Retained by Checkmate Pharmaceuticals to Identify Head of Regulatory Affairs

The Chase Group Successfully Completes Search for Vice President, Research & Development at Alexza Pharmaceuticals

The Chase Group Successfully Places David Geller, MD as Head of Pulmonary & Rare Disease Clinical Development for Arcturus Therapeutics

Head of Drug Safety Search Expands Partnership of Arcturus Therapeutics and The Chase Group

Drug Safety Leadership Team Grows at Ionis Pharmaceuticals Through Continued Partnership With The Chase Group

The Chase Group Continues Successful Collaboration with Genmab Through Placement of Vice President, CDTL

The Chase Group Retained to Identify Pulmonary and Rare Disease Clinical Development Leader for Arcturus Therapeutics

The Chase Group Successfully Secures Vice President, Head of Medical Development, for Checkmate Pharmaceuticals

Search Executed by The Chase Group, Inc. Results in Successful Appointment of Dr. Christophe Hotermans as SVP, Global Medical Affairs, for Akcea Therapeutics

Appointment of William Andrews, M.D. as Chief Medical Officer at Akcea Therapeutics Successfully Completed by The Chase Group

The Chase Group Secures New Leader for Informatics & Computational Biology at the Allen Institute for Immunology

The Chase Group Successfully Completes the Appointment of Carla Poulson as Senior Vice President/Chief Human Resources Officer at Akcea Therapeutics

The Chase Group Secures Director of Drug Safety in Copenhagen/Denmark for Genmab

Checkmate Pharmaceuticals Partners with The Chase Group for First Critical Hire in Building Their Clinical Development Team

Akcea Therapeutics Turns to The Chase Group to Secure Chief Medical Officer

Partnership With The Chase Group Results in Successful Placement for Eisai Global Oncology Business Unit

Akcea Therapeutics Retains The Chase Group to Secure Senior Vice President for Global Medical Affairs

A New Decade, A New Partnership, and Continued Growth for Alexza Pharmaceuticals and The Chase Group

Aeglea Biotherapeutics Secures Another Executive for their Clinical Development Leadership Team

The Chase Group is Retained to Secure Multiple Roles for the Eli Lilly Global Oncology Medical Affairs Leadership Team

Eisai, Inc. Retains The Chase Group to Build US Medical Affairs Leadership Team

Checkmate Pharmaceuticals Partners with The Chase Group to Build Their Clinical Development Team

Akcea Retains The Chase Group to Secure Senior HR Leader for the Company’s Executive Team

The Chase Group Drug Safety Expertise Utilized by Ionis Pharmaceuticals

The Chase Group Acquiring Talent in Denmark

Immunology Institute: Expanding the Computational Biology Team to Directly Impact Human Health

Eisai, Inc. Cuts to the Chase for Their Recruiting Expertise in Global Medical Affairs, Oncology

A New Era Begins with Head of Pathology Placement at Genmab

Through Partnership With The Chase Group, Aeglea BioTherapeutics Continues Building Rare Disease Clinical Development Leadership Team

Data Science Leadership Team Set to Expand with The Chase Group/Genmab Partnership

Eli Lilly Partnership Continues in Medical Affairs Oncology

Genmab Selects The Chase Group to Build Data Science Team

Eli Lilly Welcomes New Vice President, Immuno-Oncology Global & US Medical Affairs

Oncology Teams Set to Grow with Eli Lilly and The Chase Group Partnership

The Chase Group Secures the Vice President, US and Global Medical Affairs, for Eli Lilly

Aeglea BioTherapeutics (NASDAQ: AGLE) Partners with The Chase Group to Build Clinical Development Team for Rapidly Expanding Genetic Rare Disease Portfolio

International Next-Generation Immunotherapy Developer Partners with The Chase Group to Build New Executive Team

Ionis Pharmaceuticals Secures Associate Director, Investor Relations

The Chase Group Secures the Vice President, Global Head of Data Sciences for Genmab

Continued growth at Genmab leads back to The Chase Group in search for a Director/Senior Director, Drug Safety Physician

Esteemed Allen Institute Partners with The Chase Group for Cutting-Edge Executive Search

A Successful Placement at Eisai, Inc.

Genmab Partners with The Chase Group to Build Their Translational Research Team

Ionis Pharmaceuticals Continues to Cut to the Chase

Ipsen US Retains The Chase Group to Recruit a Vice President, Neurology Franchise Head

The Momentum Continues at Ionis Pharmaceuticals

The Chase Group Successfully Completes Vice President, Clinical Development, Respiratory for Ionis Pharmaceuticals

Client Promotion Results in New GCP QA Talent Search

Lilly Oncology Cuts to the Chase for GU Expertise

Eisai Retains The Chase Group to Find a Medical Director, Subject Matter Expert in Epilepsy

The Chase Group Recruits Newly Created Vice President of Finance Role for Ionis Pharmaceuticals

Genmab Partners with The Chase Group for Multiple Leadership Positions

Ionis Pharmaceuticals Retains the Chase Group for QA Leadership Search

Ionis Drug Safety Team Continues to Grow

Ipsen Taps The Chase Group for Sr. Business Analytics Search

Ipsen NA Cuts to the Chase Once Again!

Vice President of Finance Search

Eli Lilly Retains The Chase Group for Thoracic Oncology Medical Affairs Role

Marketing Leadership Roles Completed with Successful Placements

Eli Lilly and The Chase Group Seek GI Physician to Lead US Medical Affairs

The Chase Group Partners with Eli Lilly to Find Medical Affairs Expertise in Breast Cancer

Esperion Therapeutics Retains The Chase Group to Fill Chief Commercial Officer Role

Corporate Communications Executive Secured for Ipsen Biopharmaceuticals

The Chase Group Begins Search for Senior Marketers

IPSEN US Retains The Chase Group to Fill Executive Level Communications Leadership Role

The Momentum Continues with Eli Lilly’s Medical Affairs Organization

Senior Physician Executives Secured to Lead Oncology Medical Affairs, for Eli Lilly

Successful Placement of Global Regulatory Affairs Leader

Executive Director of Drug Safety Secured for Ionis Pharmaceuticals

Esperion Therapeutics Taps The Chase Group to Fill Newly Created Role

The Chase Group Begins Executive Director Drug Safety Recruitment

Vice President of Drug Safety for Ionis Pharmaceuticals Secured

GCP QA Leader Secured for Ionis Pharmaceuticals, Inc.

Eli Lilly Engages The Chase Group to Find GI Medical Oncologist

The Chase Group Seeks AVP for GI Medical Affairs

Thoracic Oncology Leadership Opportunity

Eli Lilly and The Chase Group Partner to Build Medical Affairs

The Chase Group Retained to Secure Immuno-Oncology Physician

Ionis Engages The Chase Group to Continue Building QA Team

Oncology Expertise in Thoracic and Breast Cancer

Dohmen Life Science Services Engages The Chase Group for Regulatory Affairs Leadership

VP of Marketing Search Closes

Five Placements Completed in Record Time for Ipsen Biopharmaceuticals

Head of Purchasing Placement at Ionis

Ipsen Retains The Chase Group for Senior Marketers

CNS Medical Affairs Search Begins

Halozyme Retains The Chase Group to Secure Clinical Team

Completion of Drug Safety Search

Ionis Pharmaceuticals Taps The Chase Group to Secure Head of Purchasing

AbbVie Global Regulatory Affairs and The Chase Group Partner Once Again!

Eli Lilly Relies on The Chase Group

The Chase Group Partners with Eli Lilly

The Chase Group Retained to Locate Medical Director of Medical Affairs

The Chase Group completes CMO search with Akcea Therapeutics

The Chase Group Secures VP of Information Technology for Ionis Pharmaceuticals

Director of Molecular and Cellular Biology Secured for Ipsen Biosciences

AstraZeneca Oncology iScience Retains The Chase Group for Chief Scientific Leadership Position

Akcea Therapeutics and The Chase Group Partner Once Again

Chief Development Officer/Chief Medical Office Secured for RRD International

Akcea Therapeutics Begins Search for Chief Medical Officer

Esperion Therapeutics Partners with The Chase Group

Ipsen Neurology Franchise VP Secured

Acorda Therapeutics and The Chase Group Partner Once Again

RRD International Retains The Chase Group

Ipsen VP Neurology Franchise Secured

Ipsen Biosciences Retains The Chase Group for Neuroendocrine Position

Durata Therapeutics and The Chase Group Partner Once Again

Ipsen US Retains The Chase Group

ImClone Retains The Chase Group

The Chase Group Continues Successful Collaboration with AbbVie in Building Their Global Regulatory Group

Chase and Lilly Diabetes Come Full Circle

Eli Lilly Retains The Chase Group

The Chase Group and Eli Lilly Oncology Business Unit Continue Successful Collaboration

Durata Therapeutics Engages The Chase Group

AbbVie Gains Top Talent

ImClone Engages The Chase Group

Eisai Retains Chase for VP Neuroscience

AbbVie Hires Global Regulatory Lead

Search Begins for Oncology Clinical Research